Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Consolidated Net Income (2016 - 2026)

Champions Oncology has reported Consolidated Net Income over the past 17 years, most recently at -$279000.0 for Q1 2026.

  • Quarterly results put Consolidated Net Income at -$279000.0 for Q1 2026, down 106.21% from a year ago — trailing twelve months through Jan 2026 was -$2.3 million (down 136.46% YoY), and the annual figure for FY2025 was $4.7 million, up 164.61%.
  • Consolidated Net Income for Q1 2026 was -$279000.0 at Champions Oncology, down from $237000.0 in the prior quarter.
  • Over the last five years, Consolidated Net Income for CSBR hit a ceiling of $4.5 million in Q1 2025 and a floor of -$2.6 million in Q3 2023.
  • Median Consolidated Net Income over the past 5 years was -$319000.0 (2022), compared with a mean of -$469117.6.
  • Biggest five-year swings in Consolidated Net Income: tumbled 12843.75% in 2023 and later soared 277.67% in 2025.
  • Champions Oncology's Consolidated Net Income stood at -$16000.0 in 2022, then tumbled by 12843.75% to -$2.1 million in 2023, then skyrocketed by 135.15% to $728000.0 in 2024, then plummeted by 67.45% to $237000.0 in 2025, then crashed by 217.72% to -$279000.0 in 2026.
  • The last three reported values for Consolidated Net Income were -$279000.0 (Q1 2026), $237000.0 (Q4 2025), and -$466000.0 (Q3 2025) per Business Quant data.